Holdings
Acuta Capital Partners, LLC
As of Jun 30, 2026, Acuta Capital Partners, LLC reported 22 positions worth US$139M. Largest: Praxis Precision Medicines, Inc., Whitehawk Therapeutics, Inc. and Tango Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | 82,796 | US$27.7M | −2,105 | Jun 30, 2026 |
| Whitehawk Therapeutics, Inc. | 4.69M | US$21.5M | +1.28M | Jun 30, 2026 |
| Tango Therapeutics, Inc. | 391K | US$12.2M | −50,882 | Jun 30, 2026 |
| Sutro Biopharma, Inc. | 270K | US$8.97M | +826 | Jun 30, 2026 |
| Arrivent Biopharma, Inc. | 219K | US$7.6M | new | Jun 30, 2026 |
| 4d Molecular Therapeutics, Inc. | 508K | US$6.75M | new | Jun 30, 2026 |
| Bright Minds Biosciences Inc. | 92,745 | US$6.51M | −19,251 | Jun 30, 2026 |
| Ocular Therapeutix, Inc. | 532K | US$5.23M | −59,627 | Jun 30, 2026 |
| Erasca, Inc. | 265K | US$4.86M | −89,376 | Jun 30, 2026 |
| Surrozen, Inc. | 173K | US$4.5M | +548 | Jun 30, 2026 |